EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Artificial intelligence in urological malignancy diagnosis and prognosis: current status and future prospects

Mingwei Zhan, Zhaokai Zhou, Jianpeng Zhang, Xin Wang, Canxuan Li, Bochen Pan, Zhanyang Luo, Wenjie Shi, Yongjie Wang, Minglun Li, Weizhuo Wang, Run Shi und 1 weitere

Canadian Journal of Urology · 2026

DOI: 10.32604/cju.2026.076084 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Canadian Journal of Urology, 2026. Verfasst von Mingwei Zhan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Hangzhou TCM Hospital of Zhejiang Chinese Medical University (Hangzhou Hospital of Traditional Chinese Medicine), Hangzhou, Ch…. Hauptthemen laut MEDLINE: Artificial Intelligence, Prostatic Neoplasms, Urologic Neoplasms, Kidney Neoplasms. Gefördert von: Hangzhou Key Project for Agricultural and Social Development, General Program of the Scientific Research Special Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artificial intelligence (AI) is transforming the diagnostic landscape of malignant tumors in the urinary system, including prostate cancer, bladder cancer, and renal cell carcinoma (RCC). By integrating imaging, pathology, and molecular data, AI enhances the precision and reproducibility of tumor detection, grading, and risk stratification. In prostate cancer, AI-assisted multiparametric Magnetic resonance imaging (MRI) and digital pathology systems improve lesion localization and Gleason scoring. For bladder cancer, deep learning-based cystoscopy and radiomics models from Computed tomography/magnetic resonance imaging (CT/MRI) enable real-time lesion segmentation and non-invasive biomarker prediction, such as Programmed Cell Death-Ligand 1 (PD-L1) expression. In RCC, AI, combined with CT/MRI and multi-omics data, aids in subtype classification and prognostic prediction, supporting personalized therapy. However, despite these promising advances, challenges such as data standardization, model generalizability, interpretability, and regulatory compliance hinder AI's clinical translation. This review outlines the current state of AI in urological cancer diagnosis and prognosis, its technological innovations, and the clinical challenges and opportunities that lie ahead.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceProstatic NeoplasmsUrologic NeoplasmsKidney NeoplasmsUrinary Bladder NeoplasmsCarcinoma, Renal CellHumansPrognosisMaleForecastingRadiomics

Stichwörter der Autor:innen

Artificial intelligencebladder cancermultimodal AIprostate cancerrenal cell carcinomaurologic cancers

Autor:innen und Institutionen

  • Department of Urology, Hangzhou TCM Hospital of Zhejiang Chinese Medical University (Hangzhou Hospital of Traditional Chinese Medicine), Hangzhou, China.
  • Department of Urology, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Department of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Department of Oncology, Jiangsu Cancer Hospital, Nanjing, China.
  • Department of Urology, Shenshan Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Shanwei, China.
  • Department of Urology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.

Förderung

  • Hangzhou Key Project for Agricultural and Social Development
  • General Program of the Scientific Research Special Project

Zitieren

APA

Zhan, M., Zhou, Z., Zhang, J., Wang, X., Li, C., Pan, B., Luo, Z., Shi, W., Wang, Y., Li, M., Wang, W., Shi, R., & Zhu, J. (2026). Artificial intelligence in urological malignancy diagnosis and prognosis: current status and future prospects. Canadian Journal of Urology. https://doi.org/10.32604/cju.2026.076084

Vancouver

Zhan M, Zhou Z, Zhang J, Wang X, Li C, Pan B, et al. Artificial intelligence in urological malignancy diagnosis and prognosis: current status and future prospects. Canadian Journal of Urology. 2026. doi:10.32604/cju.2026.076084

BibTeX
@article{Zhan2026,
  author = {Zhan, Mingwei and Zhou, Zhaokai and Zhang, Jianpeng and Wang, Xin and Li, Canxuan and Pan, Bochen and Luo, Zhanyang and Shi, Wenjie and Wang, Yongjie and Li, Minglun and Wang, Weizhuo and Shi, Run and Zhu, Jingyu},
  title = {Artificial intelligence in urological malignancy diagnosis and prognosis: current status and future prospects},
  journal = {Canadian Journal of Urology},
  year = {2026},
  doi = {10.32604/cju.2026.076084}
}
Kostenlos starten →